Litigation & Business Strategies for 503A GLP-1 Compounding: Navigating Regulatory and Legal Risks

With increasing regulatory scrutiny and rising litigation risks, 503A GLP-1 compounding is at a critical crossroads. This webinar provides essential updates, legal insights, and risk management strategies to help compounders navigate evolving FDA policies, pending lawsuits, and intellectual property concerns. What You’ll Learn: 🔸 FDA Regulations – Key changes in 503A GLP-1 compounding, especially post-removal from the 506E Drug Shortage List. 🔸 Litigation Trends – The latest updates on GLP-1 lawsuits and what they mean for compounders. 🔸 Intellectual Property Risks – How to assess the potential for patent infringement litigation. 🔸 Business & Compliance Strategies – Proactive steps to mitigate legal risks and ensure regulatory compliance. 🎙️ Frier Levitt Presenters: Martha M. Rumore, PharmD, Esq., MS, LLM, FAPhA, Jesse Dress, Esq., and Matthew Modafferi, Esq. 📅 Recorded Date: February 13, 2025 📌 Watch Now and Stay Ahead of Regulatory Changes! 🔔 Subscribe for more updates on pharmacy compounding, legal insights, and regulatory changes! #503ACompounding #GLP1Regulations #PharmacyLaw #FDARegulations #LitigationStrategies #PharmacyCompounding